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Association of Preventive Maintenance
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Alberto Monje,*†‡ Hom-Lay Wang,* and Jose´ Nart‡
Background: This study aims to investigate association
between peri-implant maintenance therapy (PIMT) and the
frequency of peri-implant diseases and to further identify fac-
tors that contribute to failure of PIMT compliance.
Methods: A cross-sectional study on patients who were
healthy and partially edentulous was conducted. They were
grouped in the following categories according to PIMT com-
pliance: 1) regular compliers (RC) (‡2 PIMT/year); 2) erratic
compliers (EC) (<2 PIMT/year); and 3) non-compliers (NC)
(no PIMT). Radiographic and clinical analyses were carried
out including probing depth (PD), plaque index (PI), bleeding
on probing (BOP), mucosal redness (MR), suppuration (SUP),
keratinized mucosa dimension, and marginal bone loss. A
multiple logistic regression model was estimated at implant
and patient level to obtain adjusted odds ratios (ORs) and to
control possible confounding effects among variables.
Results:Overall, 206 implants in 115 patients fulfilled inclusion
criteria. At patient level, it was shown that association between
compliance and peri-implant condition was statistically significant
(P = 0.04). Compliance was associated with 86% fewer condi-
tions of peri-implantitis. The probability of PIMT compliance
was substantially associated with frequency of peri-implantitis
(OR = 0.13, P = 0.01). Patients with a history of periodontal dis-
ease multiplied their probability of being EC (versus NC) 4.23
times with respect to not having a history of periodontal disease
(P = 0.02). Moreover, light smokers significantly resulted to be
NC compared with RC (P = 0.04) and EC (P = 0.02). Nevertheless,
mucositis was not found to be statistically associated with level of
compliance. In addition, PD, PI, BOP, MR, and SUP varied signifi-
cantly according to PIMT compliance and peri-implant condition.
Conclusions: Peri-implant maintenance compliance ‡2
PIMT/year seems to be crucial to prevent peri-implantitis in
healthy patients. Furthermore, history of periodontal disease
and disease severity, as well as its extent and a smoking habit,
appear to be factors that influence the compliance risk profile
(NCT02789306). J Periodontol 2017;88:1030-1041.
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L
ack of supportive periodontal main-
tenance therapy has been demon-
strated to be strongly associated
with tooth mortality.1-4 Hence, it has been
suggested that a professional mechanical
plaque removal treatment must be pro-
grammed to prevent periodontal tissue
breakdown.5 Nevertheless, early studies
in the field of periodontology pointed out
that 80% of patients do not adhere to a
regular schedule, with only 16%being com-
pliers after active periodontal therapy.1,2
It was further shown that implementing
efforts in identifying and targeting er-
ratic and non-complying individuals with
more information could increase com-
pliance to 32%.6 Biologic plausibility re-
mains due to three dominant facts: 1) in
susceptible hosts, plaque and its byprod-
ucts represent the primary etiology of peri-
odontal disease;7 2) after episodes of
inflammation, periodontal tissues aremod-
erately more susceptible due to changes
in gene expression that are not encoded
by DNA itself;8 and 3) recolonization of
putative bacteria such as spirochetes and
motile rods occurs as soon as 4 to 8
weeks after active periodontal treatment.9
Likewise, peri-implant diseases are
defined as plaque-induced chronic in-
flammatory conditions.10 Peri-implant
maintenance therapy (PIMT) has been
strongly encouraged according to pa-
tient risk profiling, with 5- to 6-month
recall intervals being suggested for non-
susceptible individuals.11 In this con-
text, it was reported that peri-implantitis
* Department of Periodontics and Oral Medicine, University of Michigan School of
Dentistry, Ann Arbor, MI.
† Department of Oral Surgery and Stomatology, Zahnmedizinische Kliniken (ZMK)
University of Bern, Bern, Switzerland.
‡ Department of Periodontology, International University of Catalunya, Barcelona, Spain.
doi: 10.1902/jop.2017.170135
Volume 88 • Number 10
1030
prevalence for individuals adhering to PIMT was 18%,
whereas for non-compliers (NC), it was 43.9%.12 More-
over, unawareness of peri-implant diseases by many
practitioners might not help to highlight the importance
of post-implant therapy enrollment on maintenance
programs for long-term success.13 Interestingly, non-
compliance rate seems to increase during a 3-year
period from 5% to 13%, with NC having a worse
prognosis than well-maintained individuals.14
Although the impact of supportive periodontal ther-
apy and recall interval has been correlated with peri-
odontal disease progression and tooth loss,4,15 there is
still a lack of information on its implication on peri-
implant diseases. As such, this study aims to investigate
association between PIMT and frequency of peri-implant
diseases and to further identify individual risk profiles
that contribute to failure of PIMT compliance.
MATERIALS AND METHODS
The present cross-sectional study was conducted in
accordance with the Helsinki declaration of human
studies and received approval from the ethics com-
mittee of the University of Extremadura, Badajoz, Spain,
and the International University of Catalunya, Barce-
lona, Spain from May 2016 to March 2017. A clinical
and radiographic cross-sectional study was conducted
in two private practices devoted exclusively to peri-
odontics and implantology (AM [Badajoz, Spain] and
JN [Barcelona, Spain]). Each participant enrolled in
the present study gave informed written consent.
Moreover, this study was registered and approved by
Clinicaltrials.gov (NCT02789306). This study was
reported in accordance with the Analysis Strength-
ening the Reporting of Observational Studies in Epi-
demiology (STROBE) Statement.16
Study Population
A total of 115 patients (69 males and 46 females, aged
23 to 79 years; mean age: 57.1 – 10.0 years) met the
inclusion criteria. All enrolled participants had to be
consecutively treated with dental implants for fixed
prosthesis rehabilitation, with a minimum period of 36
months after final prosthesis delivery. Patients were
contacted and informed about participation in clinical
and radiographic assessment to identify the presence of
peri-implant diseases. Eligible implants had to be in an
ideal prosthetically driven implant position; otherwise,
they were excluded from analysis. Moreover, implants
that could not have an accurately recorded probing
depth (PD) due to inadequate prosthesis design were
further excluded. Baseline periapical x-ray at the time of
prosthesis delivery was retrospectively assessed to ex-
clude implants with early peri-implant bone loss before
function. The high relevance of enrolling a strict PIMT
was highlighted to prevent peri-implant diseases at
treatment planning presentation. In addition, a detailed
description of risk factors and indicators of peri-implant
disease was explained at the same appointment. Pa-
tients with active periodontal disease were treated or
referred for proper diagnosis and treatment tailored
according to need. All eligible implant patients were
placed on a 5- to 6-month recall schedule. Patients with
a history of periodontal disease, smoking, or other local
conditions associated with peri-implant pathology (e.g.,
mucositis) were encouraged to attend a 3-month recall
program alternating with the referring general dental
practitioner. Additionally, patients were thoroughly in-
structed on plaque control home-care strategies in-
cluding, but not limited to, interdental brushes with
nylon-coated core wire, soft toothbrushes (manual and
power), and floss with a stiffened end to clean under
multiple-unit fixed prostheses.
Eligibility Criteria
Patients were either approached during their biannual
PIMT appointment or contacted and asked to participate
in free clinical and radiographic examination to identify
possible presence of peri-implant pathology. To attract
NC patients for study, emphasis was made on the high
frequency of peri-implant diseases and importance of
early diagnosis to ultimately prevent implant loss.
The following inclusion criteria were applied: 1) pa-
tients aged 18 to 80 years who were healthy and par-
tially edentulous (American Society of Anesthesiologists
(ASA) I-II); 2) non- or light smokers (<10 cigarettes/
day); 3) no presence of infectious diseases at time of
implant placement or during PIMT; 4) implants placed in
pristine bone; 5) no presence of serious disease or
condition known to alter bone metabolism (osteoporo-
sis, renal disease, oncologic condition, and/or treatment
or disturbance of calcium metabolism); and 6) patients
with stable periodontal condition with or without history
of chronic periodontitis. On the contrary, individuals
were excluded for the following reasons: 1) pregnancy;
2) history of heavy smoking; 3) uncontrolled medical
conditions such as diabetes mellitus (DM); 4) inade-
quate implant position (i.e., prosthetically driven); 5)
implant not properly restored impeding accurate PD
recording; 6) cement-retained restorations; or 7) lack of
minimal band of 2 mm of keratinized mucosa (KM).
Study Outcomes
The primary outcome of the present study is to an-
alyze frequency of peri-implant diseases at implant
and patient level according to their compliance with
professional oral health care after implant placement.
As secondary outcomes, it aims to identify frequency
of compliance and to further assess individual risk
profiles that contribute to failure of PIMT compliance.
Study Groups
Sample size calculation was based on Cohen F test to
achieve power of 80% at effect size and probability
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level of 0.05 with confounding factors and covariates.
Therefore, patients were grouped as regular com-
pliers (RC), erratic compliers (EC), or non-compliers
(NC), as described elsewhere.2 As such, complete
compliance was based on the longest PIMT recall
interval possible for each group.
Groups were:
d RC = 3- to 6-month recall interval (‡2 PIMT/year)
d EC = 7- to 12-month recall interval (<2 PIMT/year)
d NC = no recall interval program (no PIMT/year)
Patients who participated in a recall schedule but
discontinued PIMT in future appointments were cat-
egorized as EC or NC according to their compliance
during the following years.
Peri-Implant Maintenance Therapy Protocol
Review of medical and dental history was performed,
followed by clinical evaluation of implant(s) and, if
needed due to presence of apparent inflammation,
combined with deep PD (>5 mm); a periapical radio-
graph was taken to evaluate peri-implant bone level.
Briefly, during regular PIMT appointments, oral hygiene
was assessed in the remaining dentition and dental
implants by means of plaque and debris accumulation.
Therapy provided at the maintenance appointment
included removal of plaque and calculus, utilizing
curets, plastic-tip ultrasonic devices, and rubber cup
low-speed polish as suggested elsewhere by the
American Academy of Periodontology position pa-
per.17 Furthermore, interdental brushes with nylon-
coated core wire along with floss with a stiffened end
were used to thoroughly remove any biofilm attached
to interproximal subgingival areas. An explorer in-
strument was used to check complete removal of bi-
ofilm on the implant surface. Chlorhexidine 0.12% was
provided to rinse for 30 to 40 seconds after therapy was
concluded. Behavior modification (tobacco cessation,
oral hygiene instruction, and systemic factor counsel-
ing) was addressed based on patient findings.
Case Definition of Mucositis
As suggested by the American Academy of Peri-
odontology position paper18 and the VIII European
Federation of Periodontology,10mucositis was defined as
an inflammatory condition that courses with swelling
(tumor) and bleeding in the lack of radiographic peri-
implant marginal bone loss (MBL). As such, implants
with no bleeding, or only bleeding on probing (BOP) at
one surface assuming a point of bleeding as a con-
sequence of trauma from probing, no suppuration
(SUP), and bone loss <2.0 mm, were considered
healthy. On the other hand, overt bleeding19 (at least
two sites to exclude positive BOP as a consequence
of trauma from probing)20 or tissue edema with
minimal isolated (one site per implant) or no SUP was
defined as mucositis.
Case Definition of Peri-Implantitis
Definition of peri-implantitis was based on clinical
inflammation combined with radiographic bone loss.
Accordingly, peri-implantitis was defined as the
presence of clinical inflammation in combination with
radiographic bone loss >2 mm, as earlier proposed
by the VIII European Workshop on Periodontal Dis-
eases by the European Federation of Periodontol-
ogy.10 The landmark used to evaluate peri-implant
bone level was the neck in the case of rough full-
bodied implants or the rough-to-smooth interface in
the case of tissue-level implants. As such, signs such
as presence of SUP, BOP, redness, and PD were
recorded at six sites per implant applying 0.15 N/cm
force as suggested by the American Academy of
Periodontology position paper.18
Radiographic Assessment
Peri-implant MBL was determined by taking linear
measurements from the most mesial and distal points
of the implant neck to the crestal bone on each peri-
apical radiograph, corrected according to knownheight
and width of each implant using image software.§ For
tissue-level implants, the interface between rough–
smooth surfaces was taken as reference to assess MBL.
Moreover, a baseline x-ray (after prosthesis delivery)
was obtained from records to measure biologic width
establishment (physiologic MBL) to determine pro-
gressing bone loss as a consequence of an inflam-
matory condition (i.e., peri-implantitis).
Clinical Assessment
The following clinical parameters were recorded: 1) PD;
2) plaque index (PI);21 3) BOP; 4) presence of mucosal
redness (MR); and 5) SUP. All these aforementioned
parameters were recorded at six sites per implant, and
KM at buccal and lingual aspects was recorded. History
of periodontal disease, severity (mild, moderate, se-
vere), and extent (localized, generalized) were further
recorded from patient records according to the Amer-
ican Academy of Periodontology Task Force Classifi-
cation (2016).22 In addition, the habit of light smoking
(<10 cigarettes/day) was monitored to study associ-
ation with compliance and peri-implant diseases.
Statistical Analyses
Data were calculated at patient and implant level.
Inferential analysis was carried out, including esti-
mation of simple binary logistic regression models
with dependent variable level of compliance (RC
versus EC, RC versus NC, EC versus NC) and each
of the independent factors, for estimation of un-
adjusted odds ratio (OR). The model estimated
unadjusted ORs along with 95% confidence intervals.
Once significant factors were identified (presence, se-
verity, and extension of history of periodontal disease),
§ ImageJ, National Institutes of Health, Bethesda, MD.
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a multiple logistic regression model was estimated to
obtain adjusted ORs and to control possible confound-
ing effects among variables. Level of significance used
in analyses was 5% (a = 0.05).
A logit model for association between outcome and
an independent factor of two levels was conducted, to
reach a power of 80% to detect OR = 3.0 as statistically
significant, assuming a level of confidence of 95%.
Such an OR would be equivalent to proportions of
compliance of 25% and 50% in two groups of patients.
The highest level of compliance was considered the
event whose probability is modeled with the regression.
Accordingly, for a continuous variable (age, mean
MBL), OR was interpreted as the amount by which
risk of a higher degree of compliance was multiplied
when the variable increased one unit (1 mm of MBL).
For a categoric factor, OR was interpreted as the
amount by which the risk of a higher degree of
compliance was multiplied when it was compared
with the level of a certain factor with respect to the
first (reference factor OR = 1).
For implant-level analysis, a logit model was es-
timated applying the generalized estimated equa-
tions. Dependent variables were the degree of PIMT
compliance and peri-implantitis. Effects of possible
prognostic factors were evaluated applying x2 de
Wald at a level of significance of 5% (a = 0.05).
RESULTS
Demographics
A total of 153 patients with 241 implants were
screened for eligibility. Overall, 206 implants placed
in 115 patients, with mean follow-up of 46.85 – 5.80
months (range: 36 to 55 months), met the inclusion
criteria and were clinically and radiographically an-
alyzed. Six implant systems were evaluated. i¶#**††‡‡
Of them, 153 were bone-level implants, 28 were
tapered-internal implants, and the remaining 25 were
tissue-level implants. All implants assessed sup-
ported fixed prostheses (146 fixed prostheses and 60
single crowns).
Association Between Compliance and
Peri-Implant Diseases at Patient Level
The association between compliance and peri-implant
conditionwas statistically significant (P = 0.04).Within
RC, although 72.7% were healthy, 4.5% had peri-
implantitis. On the contrary, only 53.5% NC, encom-
passing EC and NC, were healthy, whereas a mean of
23.9% had peri-implantitis (OR = 0.14, P = 0.01). In
other words, compliance was associated with 86%
fewer conditions of peri-implantitis. Similarly, pres-
ence of peri-implantitis was significantly less associ-
ated with regular compliance (OR = 0.19, P = 0.10). On
the other hand, mucositis was equal for both groups
(OR = 0.74, P = 0.52).
Association Between Compliance Degree and
Peri-Implant Diseases at Patient Level
Table 1 displays an association between degree of
PIMT compliance and independent factors. Find-
ings for the primary objective demonstrated that
compliance was significantly associated with peri-
implantitis. Prevalence of peri-implantitis was
4.5%, 26.3%, and 14.3% for RC, EC, and NC, re-
spectively, but no association was found either with
incidence of mucositis or when RC and EC were
compared with NC. Moreover, probability of devel-
oping peri-implantitis was substantially associated
with reduction in EC compared with RC (OR = 0.13,
P = 0.01) (Figs. 1A and 1C).
Indicators on Peri-Implant Maintenance Therapy
Compliance at Patient Level
It was found that patients with history of periodontal
disease had 4.23 times the probability of being EC
(versus NC) compared with patients with no history
of periodontal disease (P = 0.02). As such, 35.7%,
70.2%, and 63.6% were NC, EC, and RC, respec-
tively, with history of periodontal disease. The same
trend (OR = 3.15), without reaching significance (P =
0.07), was observed for RC (versus NC). Moreover,
when comparing RC to EC, it was identified that
having a history of moderate periodontal disease was
less associated with being fully compliant compared
with mild periodontal disease (OR = 0.25, P = 0.04). A
history of a severe degree of periodontal disease
showed less compliance compared with history of
mild periodontal disease status (OR = 0.19, P = 0.07).
Furthermore, the generalized type of periodontal
disease was significantly more associated with be-
ing RC (versus NC) compared with the localized cat-
egory of periodontal disease (OR = 18.0, P = 0.04).
Light smokers resulted in being NC compared with
RC (OR = 0.18, P = 0.04) and EC (OR = 0.14, P = 0.02).
It was also found that for each 1-mm increase of MBL,
probability of being RC (versus EC) was signifi-
cantly less (OR = 0.28, P = 0.001). Likewise, NC had
more MBL compared with RC; however, no statistical
significance was found compared with the EC group
(OR = 0.34, P = 0.07).
Association Between Compliance Degree and
Peri-Implant Diseases at Implant Level
Association between compliance and peri-implantitis
reached statistical significance (P = 0.02). Overall,
78.3% of healthy implants were allocated within RC;
however, only 65.9% were observed in NC (EC and
i Nobel Biocare, Kloten, Switzerland.
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NC). Conversely, frequency of peri-implantitis at
implant level was significantly associated with NC
(EC and NC) (OR = 0.12, P = 0.004). In this sense,
implants under strict compliance were highly as-
sociated with health (88%). Mucositis, on the con-
trary, did not reach significance when comparing
both groups (OR = 0.95, P = 0.91) (Figs. 1B and 1D).
Association Between Compliance Degree and
Peri-implant Diseases at Implant Level
Table 2 displays degree of PIMT compliance and
independent factors. It was found that, whereas
peri-implant mucositis did not seem to be associated
with level of compliance, being EC was significantly
associated with the condition of peri-implantitis (OR =
0.11; P = 0.003). As such, whereas only 2.4% of
implants were diagnosed with peri-implantitis in the
RC group, 19% and 8.7% belonging to the EC and NC
groups, respectively, had peri-implantitis.
Indicators on Peri-Implant Maintenance Therapy
Compliance at Implant Level
Similarly, data regarding indicators on PIMT com-
pliance are presented in Table 2. In summary, mean
Table 1.
Association Between Degree of PIMT Compliance and Independent Factors as Result of
Applying Simple Binary Logistic Regression Analysis to Calculate ORs
Variable
RC Versus EC RC Versus NC EC Versus NC
OR P Value OR P Value OR P Value
Age 1.01 0.56 0.96 0.20 0.94 0.08
Sex
Males 1 1 1
Females 1.85 0.13 2.50 0.17 1.35 0.65
History of periodontal disease
No 1 1 1
Yes 0.74 0.49 3.15 0.07 4.23 0.02*
Severity of periodontal disease
Mild 1 1 1
Moderate 0.25 0.04* — — — —
Severe 0.19 0.07 — — — —
Extent of periodontal disease
L 1 1 1
G 5.73 0.11 18.0 0.04* 3.14 0.25
Smoking (<10 cig/day)
No 1 1 1
Yes 1.32 0.74 0.18 0.04* 0.14 0.02*
MBL (mm) 0.28 0.001† 0.34 0.07 1.42 0.44
Peri-implantitis case definition ‡2 mm MBL
Healthy 1 1 1
Mucositis 0.78 0.62 0.63 0.51 0.80 0.75
Peri-implantitis 0.13 0.01† 0.25 0.20 2.00 0.42
Peri-implantitis case definition ‡3 mm MBL
Healthy 1 1 1
Mucositis 0.51 0.15 0.42 0.18 0.82 0.74
Peri-implantitis 0.28 0.13 — — — —
Peri-implantitis case definition ‡4 mm MBL
Healthy 1 1 1
Mucositis 0.47 0.08 0.50 0.28 1.08 0.90
Peri-implantitis — — — — — —
— = not applicable; L = localized; G = generalized; cig = cigarettes.
* P <0.05.
† P <0.01.
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PI was found to be strongly and moderately associ-
ated with compliance between RC and EC versus NC
(OR = 0.09, P = 0.002 and OR = 0.19, P = 0.04, re-
spectively). In addition, for each 1-mm MBL in-
crement, the association of being RC (versus EC) was
significantly less (OR = 0.42, P = 0.01). PD also
represented a sensitive indicator for PIMT compliance
level. Accordingly, for each 1-mm PD increase, the
association of being RC (versus EC) was substan-
tially reduced (OR = 2.73, P = 0.001). Statistical
significance was further reached when comparing RC
versus NC (OR = 2.63, P = 0.002). On the other hand,
SUP was more sensitive to NC versus EC (OR = 11.6,
P = 0.04), favoring for EC, whereas no significance
was reached when comparing NC versus RC (OR =
6.12, P = 0.17).
Clinical Indicators of Peri-Implant Conditions
Mean PI was only sensitive to diagnose peri-
implantitis compared with health (OR = 4.48, P =
0.02) but not mucositis (OR = 1.39, P = 0.52)
(Table 3).
Mean BOP was a sensitive parameter to discern
mucositis compared with health (OR = 5.42, P =
0.001). This was significantly incremental to OR = 15
when peri-implantitis was diagnosed (P <0.001).
Mean PD was sensitive to significantly discriminate
among the three groups. Accordingly, likelihood of
developing mucositis versus healthy (OR = 1.52; P =
0.01), peri-implantitis versus healthy (OR = 2.37;
P <0.001), and peri-implantitis versus mucositis
(OR = 1.69; P = 0.03) resulted statistically significantly
to be accurately diagnosed based solely on the PD.
Mean MR was strongly associated with mucositis
(OR = 60.9, P <0.001) and peri-implantitis (OR =
16.3, P <0.001) compared with healthy individuals.
However, it was lower for peri-implantitis compared
with mucositis (OR = 0.22, P = 0.05).
Mean SUP was a strongly sensitive value to
diagnose peri-implantitis (OR = 20.3, P <0.001)
(Fig. 2, Table 3).
DISCUSSION
Main Findings and Agreements/Disagreements
With Previous Findings for Primary Outcome
Peri-implant disease, as with periodontal disease,
represents a chronic inflammatory entity promoted
by microbial biofilm in susceptible hosts. Accord-
ingly, disruption of the assemblage of surface-
associated microbial cells enclosed in an extracellular
polymeric matrix must be routinely removed through
self-performed oral hygiene measures. In addition,
professional preventive therapies, including strate-
gies for early diagnosis of pathology and early re-
moval of precipitant irritants, must be adopted to
ensure long-term successful outcomes.23 Based on
this, PIMT compliance represents the key to achiev-
ing an inflammation-free environment that could
achieve harmony between hard and soft tissue sta-
bility.24 For instance, it was demonstrated that dental
implant failure rate was reduced by 90% in patients
who had regularmaintenance versus nomaintenance.
Figure 1.
Peri-implant radiographic MBL at (A) patient level and (B) implant level. Peri-implant conditions (%) according to compliance regimen at (C) patient
level and (D) implant level.
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Additionally, for ‘‘patients that had <1 maintenance
visit/year, failure rate was reduced by 60% compared
with no maintenance.’’25 In this respect, it has been
reported that patients attending to routine PIMT are
significantly less exposed to peri-implant bone loss
progression.12,26 In a comparative 12-month study, it
was found that PIMT every 4 months potentially re-
duces risk of developing peri-implantitis compared
with no PIMT (3.7% versus 22.7% at patient level, re-
spectively).27 Strikingly, a long-term assessment ob-
served 8.5% of peri-implantitis at implant level for
patients attending at least twice per year (£6
months), whereas for those who adhered once per
year (>6 months), incidence was slightly higher at
9.3%.28 Likewise, a recent systematic review high-
lighted the need of administrating peri-implant mainte-
nancemeasures at least twice a year to decrease rate
of peri-implantitis from 36.5% to 12.5% at patient
level.11 This was further demonstrated in another
review paper, where it was concluded that implant
therapy can be successfully applied in patients with
a diagnosis of periodontitis as long as they regularly
attend a proper periodontal maintenance pro-
gram.29 In agreement with the aforementioned
studies, findings from the present trial demonstrate that
NC or EC individuals are substantially more exposed to
developing peri-implant diseases because a positive
association was found. As such, peri-implantitis was
86% less associated, at patient level, for patients
adhering to a well-organized PIMT. Additionally,
frequency of peri-implantitis concerning NC re-
ported in the present cohort study agreed with
findings published elsewhere.30 This highlights the
importance of supplying proper oral hygiene in-
struction along with strict enrollment of PIMT re-
gimes according to patient risk profiling.23,31
Main Findings and Agreement/Disagreement
With Previous Findings for Secondary Outcomes
Patient compliance has been demonstrated to be
an essential factor for the prevention of periodonti-
tis3,4,32,33 and peri-implantitis.12,34-37 Nevertheless,
it seems that because of many practitioners’ and
patients’ misperception and misunderstanding that
implants are life-lasting fixtures without need for
enrollment in a regular PIMT program,13 PIMT has not
been frequently implemented as part of the treatment
plan. Besides, several influencing factors, such as
Table 2.
Association Between Degree of PIMT Compliance and Independent Factors Analyzed
Applying Generalized Estimation Equations for Logistic Simple Binary Logistic Regression
Analysis to Calculate ORs
Variable Condition
RC Versus EC RC Versus NC EC Versus NC
OR P Value OR P Value OR P Value
MBL (mm) 0.42 0.006* 0.51 0.14 1.33 0.28
PI (I/0) 0.39 0.05 0.09 0.002* 0.19 0.04†
BOP (I/0) 0.49 0.14 0.96 0.96 2.02 0.47
PD (mm) 0.95 0.72 2.63 0.002* 2.73 0.001*
MR (I/0) 0.74 0.52 0.74 0.72 1.00 0.99
SUP (I/0) 0.52 0.24 6.12 0.17 11.6 0.04†
Peri-implantitis case definition ‡2 mm MBL Healthy 1 1 1
Mucositis 1.08 0.87 0.62 0.53 0.57 0.45
Peri-implantitis 0.11 0.003* 0.23 0.14 2.16 0.31
Peri-implantitis case definition ‡3 mm MBL Healthy 1 1 1
Mucositis 0.63 0.31 0.46 0.25 0.73 0.61
Peri-implantitis 0.29 0.12 — — — —
Peri-implantitis case definition ‡4 mm MBL Healthy 1 1 1
Mucositis 0.58 0.18 0.52 0.31 0.89 0.86
Peri-implantitis — — — — — —
1 = yes; 0 = no; — = not applicable.
* P <0.01.
† P <0.05.
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Table 3.
Association Between Peri-Implantitis (‡2 mm MBL) and Independent Factors Analyzed
Applying Generalized Estimation Equations for Logistic Simple Binary Logistic Regression
Analysis to Calculate ORs
Variable
M Versus H P-I Versus H P-I Versus M
OR P Value OR P Value OR P Value
Age 1.00 0.95 1.01 0.72 1.01 0.82
Sex
Males 1 1 1
Females 1.80 0.20 1.86 0.20 1.03 0.96
History of periodontal disease
No 1 1 1
Yes 0.94 0.90 2.03 0.15 2.16 0.23
Severity of periodontal disease
Mild 1 1 1
Moderate 0.54 0.34 4.64 0.16 8.66 0.08
Severe 2.22 0.39 6.66 0.10 3.00 0.44
Extent of periodontal disease
Localized 1 1 1
Generalized 0.50 0.39 0.55 0.54 1.09 0.91
Implant position
Mandibular anterior 1 1 1
Mandibular posterior 0.51 0.23 — — — —
Maxillary anterior 0.63 0.47 — — — —
Maxillary posterior 0.44 0.14 — — — —
Implant system
** 1 1 1
i 1.66 0.54 1.02 0.98 0.62 0.67
§ 0.78 0.77 2.75 0.20 3.50 0.22
¶ 2.25 0.29 0.500 0.59 0.22 0.24
Implant neck design
Bone level 1 1 1
# 0.78 0.74 0.46 0.32 0.59 0.60
Tissue level 2.01 0.18 — — — —
Smoking (<10 cigs/day)
No 1 1 1
Yes 0.90 0.93 0.97 0.97 1.08 0.95
Plaque (I/0) 1.39 0.52 4.48 0.024* 3.73 0.14
BOP (I/0) 5.42 0.001† 15.0 <0.001‡ 2.81 0.20
PD (mm) 1.52 0.01* 2.37 <0.001‡ 1.69 0.03*
MR (I/0) 60.9 <0.001‡ 16.3 <0.001‡ 0.22 0.05
SUP (I/0) 7.03 0.003† 20.3 <0.001‡ 2,48 0.22
M = mucositis; H = healthy; — = not applicable; cig = cigarettes; 1 = yes; 0 = no.
* P <0.05.
† P <0.01.
‡ P <0.001.
§ Nobel Biocare, Kloten, Switzerland.
i Mozo Grau Ticare, Valladolid, Spain.
¶ Straumann, Basel, Switzerland.
# LaserLok, Biohorizons, Birmingham, AL.
** Biohorizons.
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geographic distance to the dental practice or con-
ditions such as smoking or DM, have also been as-
sociated with erratic compliance.14
By any means, patient compliance has been shown
to vary widely among different environments.
Whereas some studies reported high compliance rates
of 77% during 5 years38 and £93% during 10 years,39
others had found lower rates of 30%40 during 9- to
14-year follow-up. This evidence does not seem to
indicate that compliance is higher in implant patients
compared with non-implant carriers.2,33,41,42 Never-
theless, it is worth noting that patient compliance
decreases with time,14 and thereupon, the risk for
having peri-implant disease increases. Hence, it is
important to emphasize the need to have adequate
and regular professional and personal plaque control.
This is especially remarkable for patients who had
implants for >3 years because greater disease onset is
exhibited at this timepoint.43 The present study is in
partial agreement with previous studies according to
the case-definition applied for compliance. For in-
stance, in a 3-year follow-up clinical study, Frisch
et al.14 noted compliance of 84%; however, the au-
thors defined compliance as ‡1 visit/year. Therefore, if
such a definition is applied to the present data, 87.8%
belonged to the RC group, thus agreeing with earlier
findings.14,38,39 Moreover, although without reaching
statistical significance, it was elucidated that females
and individuals with a history of periodontal disease
have a higher trend to comply more regularly. In
accordance with a previous report,14 this could be
understood because there is a higher awareness of
individuals enrolled in supportive periodontal therapy.
Interestingly, the vast majority of these patients were
grouped within the EC category. This fact might have
led to finding higher peri-implantitis frequency in EC
compared with NC by 10% at patient and implant
level. In addition, the habit of light smoking (£10
cigarettes/day) was significantly less associated with
RC. This finding was previously reported by Ramseier
et al.44 for patients enrolled in supportive periodontal
therapy after periodontal therapy or prophylaxis.
This might be explained by the patients’ poor regard
or belief that their actions/habits impact their
Figure 2.
Peri-implant clinical parameters according to peri-implant conditions. A) PI; B) BOP; C) PD; D)MR; and E) SUP.
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health45 or it might also reflect patient shame to-
ward not fulfilling the recommendations of smoking
cessation.
Into the bargain, as clinical parameters such as PD,
BOP, MR, and SUP in the current cohort showed
acceptable sensitivity to discern the peri-implant
conditions, it is encouraged that the clinician and
dental hygienist periodically record and monitor
them on a regular basis to assist in early diagnosis of
mucositis, where the pathology is yet reversible.46
These findings are thus consistent with earlier find-
ings in regard to PD and BOP as indicators of peri-
implant disease progression47 and recent studies
concerning BOP48,49 and implant mucosal status.50
Limitations and Recommendations for Future
Research
Caution must be exercised when interpreting the
findings of the present study. First, based on the study
design under a cross-sectional basis, a ‘‘cause–effect’’
relationship cannot be drawn, but the ‘‘association’’
between peri-implant conditions and patient compli-
ance could be demonstrated. Moreover, it must be
noted that, although the protocols/instructions of both
private practices followed the recommendations for
periodontal and peri-implant maintenance by the
American Academy of Periodontology position pa-
per,17 there might be certain bias elicited. Addition-
ally, when compared with other epidemiologic studies
on peri-implant diseases, the case definition must be
adequately interpreted. As such, when an alternative
case definition was applied (i.e., peri-implant bone
loss ‡3 to 4 mm with signs of inflammation), the
prevalence of peri-implant diseases dropped sub-
stantially for the three groups evaluated, not reaching
statistical significance among groups. Hence, it is the
current authors’ desire to call for future controlled
longitudinal studies where the impact of PIMT on peri-
implant diseases can be validated applying different
case definitions for peri-implantitis.
CONCLUSIONS
Peri-implant maintenance compliance ‡2 PIMT/year
seems to be crucial to prevent peri-implantitis in
healthy patients. History of periodontal disease and
disease severity, as well as its extent and a smoking
habit, appear to be factors that influence compliance
risk profile. Further long-term studies are warranted
to identify different strategies to effectively increase
patient adherence to preventive peri-implant main-
tenance programs.
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